Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program

MLA

Matthews, Dr, et al. Effects of Canagliflozin on Amputation Risk in Type 2 Diabetes: The CANVAS Program. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1183379509&authtype=sso&custid=ns315887.

APA

Matthews, D., Li, Q., Perkovic, V., Mahaffey, K., de Zeeuw, D., Fulcher, G., Desai, M., Hiatt, W., Nehler, M., Fabbrini, E., Kavalam, M., Lee, M., & Neal, B. (2019). Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program.

Chicago

Matthews, Dr, Q Li, V Perkovic, Kw Mahaffey, D de Zeeuw, G Fulcher, M Desai, et al. 2019. “Effects of Canagliflozin on Amputation Risk in Type 2 Diabetes: The CANVAS Program.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1183379509&authtype=sso&custid=ns315887.